We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ENDO, FDA AGREE ON TRIAL DESIGN FOR NEW OXYMORPHONE DRUG
ENDO, FDA AGREE ON TRIAL DESIGN FOR NEW OXYMORPHONE DRUG
July 7, 2004
Endo Pharmaceuticals has reached an agreement with the FDA on the design of a new clinical trial to confirm the safety and efficacy of its experimental pain drug, oxymorphone extended-release (ER) tablets, the firm said yesterday.